Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Inclusion criteria * Male and female patients of any race 18 years or older * Adult recipients of a kidney transplant from a deceased or from a living donor * Recipients of a functioning Kidney:. Graft must be functional no later than 36h after transplantation. Exclusion criteria * Need for medication prohibited by the protocol * Patients or donors infected with hepatitis B or C, or with HIV. * Patients with a history of cancer * Patients with severe systemic infections Patients with heart diseases (own or family history) which are associated with an increased risk for arrhythmias. Other protocol-defined inclusion/exclusion criteria may apply